المؤلفون: D. S. Gordeeva, S. F. Nasibullin, A. G. Karpov, V. V. Khutoryanskiy, R. I. Moustafine

المصدر: Разработка и регистрация лекарственных средств, Vol 13, Iss 3, Pp 93-102 (2024)

مصطلحات موضوعية: eudragit® epo, phenylboronic acid, nasal delivery, mucoadhesion, transmucosal delivery systems, Pharmaceutical industry, HD9665-9675

وصف الملف: electronic resource

Relation: https://www.pharmjournal.ru/jour/article/view/1921; https://doaj.org/toc/2305-2066; https://doaj.org/toc/2658-5049

URL الوصول: https://doaj.org/article/28b2a20f8e8947289928db884b08b1de

المؤلفون: P. Monika, M.N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja

المصدر: Hybrid Advances, Vol 7, Iss , Pp 100334- (2024)

مصطلحات موضوعية: Pomegranate peel extract, Eudragit L-100, Ulcerative colitis, Bioavailability, Targeted drug delivery, Anti-inflammatory activity, Technology

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2773207X24001957; https://doaj.org/toc/2773-207X

URL الوصول: https://doaj.org/article/f6bcd172f8af48f1a135a6c962eedc72

المؤلفون: Vanessa Domsta, Tessa Boralewski, Martin Ulbricht, Philipp Schick, Julius Krause, Anne Seidlitz

المصدر: International Journal of Pharmaceutics: X, Vol 8, Iss , Pp 100263- (2024)

مصطلحات موضوعية: Hot-melt extrusion, Eudragit® RS, Ethyl cellulose, Polyethylene oxide, Dexamethasone, Degradation, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2590156724000355; https://doaj.org/toc/2590-1567

URL الوصول: https://doaj.org/article/38eac8f9968b43e7a427b672c7a615b3

المؤلفون: Patel, Jaymin^{1, 2}, Patel, Kaushika¹, Shah, Shreeraj^{1, 1}

المصدر: Research Journal of Pharmacy and Technology 17(4):1531-1536. 2024

المؤلفون: Prathamesh S. Patil, M. Pharm, Sushank J. Suryawanshi, M. Pharm, Sharvil S. Patil, M. Pharm, Ph.D., Atmaram P. Pawar, M. Pharm, Ph.D.

المصدر: Journal of Taibah University Medical Sciences, Vol 19, Iss 2, Pp 252-262 (2024)

مصطلحات موضوعية: Dispersible tablets, Dissolution, Eudragit EPO, Hot melt extrusion, Taste masking, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1658361223002627; https://doaj.org/toc/1658-3612

URL الوصول: https://doaj.org/article/6525051ecfe249c9b1ae6a63341be678

المؤلفون: Chiara G. M. Gennari, Antonella Casiraghi, Francesca Selmin, Francesco Cilurzo

المصدر: Pharmaceutics, Vol 17, Iss 1, p 88 (2025)

مصطلحات موضوعية: drug delivery system, Eudragit® E, film-forming solution, plasticizer, skin permeability, supersaturation, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1999-4923/17/1/88; https://doaj.org/toc/1999-4923

URL الوصول: https://doaj.org/article/7e7629643b6b4b42b88e349b54cc9f05

المؤلفون: Seong-Jin Park, Gyu Lin Kim, Hyo-Kyung Han

المصدر: Pharmaceutics, Vol 16, Iss 12, p 1617 (2024)

مصطلحات موضوعية: hydrophilic polymer, solubilization, dissolution, poloxamer 407, Eudragit® RSPO, bioavailability, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1999-4923/16/12/1617; https://doaj.org/toc/1999-4923

URL الوصول: https://doaj.org/article/b483bfc0f8654685bda1ba183c7fd8ad

المؤلفون: Shinde, Anilkumar J.^{1, 1}, Khandekar, Sachin S.¹, Bhatia, Manish S.², Tamboli, Firoj A.³, Jarag, Ravindra J.⁴, More, Harinath N.¹

المصدر: Research Journal of Pharmacy and Technology 16(12):5775-5781. 2023

المؤلفون: Valentina Parisi, Valentina Santoro, Immacolata Faraone, Nadia Benedetto, Antonio Vassallo, Nunziatina De Tommasi, Luigi Milella, Antonio Nesticò, Gabriella Maselli, Anna Maria Fadda, Carla Caddeo

المصدر: Frontiers in Plant Science, Vol 15 (2024)

مصطلحات موضوعية: Sonchus asper (L.) Hill extract, eudragit-coated liposomes, antioxidant, hypoglycemic, GLP-1, economic evaluation, Plant culture, SB1-1110

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpls.2024.1416539/full; https://doaj.org/toc/1664-462X

URL الوصول: https://doaj.org/article/965eb989850848de97bb700cb56f4854

المؤلفون: Pham Duy Toan, Nguyen Ngoc Yen, Nguyen Quoc Chau Thanh, Quach Thi Hong Dung, Ha Thi Kim Quy

المصدر: Tạp chí Khoa học Đại học Cần Thơ, Vol 60, Iss 4 (2024)

مصطلحات موضوعية: Eudragit E100, fibroin, hệ vi hạt, poly(vinyl alcohol), tơ tằm, Science

وصف الملف: electronic resource

Relation: https://ctujsvn.ctu.edu.vn/index.php/ctujsvn/article/view/5656; https://doaj.org/toc/1859-2333; https://doaj.org/toc/2815-5599

URL الوصول: https://doaj.org/article/0b896474444f4a90ae1ea78d6fd37967

المؤلفون: M. S. Heya, M. J. Verde-Star, C. Rivas-Morales, D. G. García-Hernández, A. Tijerina-Sáenz, M. López-Cabanillas-Lomelí, R. Álvarez-Román, S. A. Galindo-Rodríguez

المصدر: Brazilian Journal of Biology, Vol 84 (2024)

مصطلحات موضوعية: dermatophytes, eudragit, anti-dermatophytic, nanoformulated, Science, Biology (General), QH301-705.5, Zoology, QL1-991, Botany, QK1-989

وصف الملف: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000101190&lng=en&tlng=en; http://www.scielo.br/pdf/bjb/v84/1519-6984-bjb-84-e275974.pdf; https://doaj.org/toc/1678-4375

URL الوصول: https://doaj.org/article/2b1f7f822bef46a3af3c90d96c2b3493

المؤلفون: Ahlam Zaid Alkilani, Sara Omar, Jehad Nasereddin, Rania Hamed, Rana Obeidat

المصدر: Heliyon, Vol 10, Iss 14, Pp e34212- (2024)

مصطلحات موضوعية: Dexamethasone, Solid dispersion, HPMC, Polymer, Eudragit S 100, Colon drug delivery, Science (General), Q1-390, Social sciences (General), H1-99

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024102435; https://doaj.org/toc/2405-8440

URL الوصول: https://doaj.org/article/3e74a10bbe5c4cc5ad7993ecbc9f4cb5

المؤلفون: I. D. Kasymov, A. L. Marchenko, A. V. Basevich, M. E. Valeeva

المصدر: Разработка и регистрация лекарственных средств, Vol 12, Iss 4, Pp 146-154 (2023)

مصطلحات موضوعية: microcapsulation, emulsion solvent diffusion method, ibuprofen, eudragit, Pharmaceutical industry, HD9665-9675

وصف الملف: electronic resource

Relation: https://www.pharmjournal.ru/jour/article/view/1649; https://doaj.org/toc/2305-2066; https://doaj.org/toc/2658-5049

URL الوصول: https://doaj.org/article/306c47a97d9941a09a1a7ab10347e270

المؤلفون: Aamir Hayyat, Nabeel Siddique

المصدر: Pharmaceutical Sciences and Research, Vol 10, Iss 2, Pp 107-116 (2023)

مصطلحات موضوعية: ropinirole hcl, eudragit® rs 100, eudragit® rl 100, solvent emulsion evaporation technique, microparticles, sustained release, Pharmacy and materia medica, RS1-441, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://scholarhub.ui.ac.id/psr/vol10/iss2/6/; https://doaj.org/toc/2407-2354; https://doaj.org/toc/2477-0612

URL الوصول: https://doaj.org/article/aff0c75866884c9992fe7ef819b174b1

المؤلفون: Andayani, Regina, Hasbi, Febriyenti¹

المصدر: Research Journal of Pharmacy and Technology 16(11):5279-5284. 2023

المؤلفون: Andiran, V.^{1, 1}, Kannan, K.²

المصدر: Research Journal of Pharmacy and Technology 16(3):1041-1046. 2023

المؤلفون: E. Yu. Lomakina, M. V. Teberdieva, Yu. M. Buzunova, E. A. Belousova, Е. Ю. Ломакина, М. В. Тебердиева, Ю. М. Бузунова, Е. А. Белоусова

المصدر: Meditsinskiy sovet = Medical Council; № 15 (2024); 182–189 ; Медицинский Совет; № 15 (2024); 182–189 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: стратегия Т2Т, aminosalicilates, inflammatory bowel disease, enteric coating, Eudragit L, Eudragit S, pH-dependent release, Тreat-to-Тarget strategy, аминосалицилаты, воспалительные заболевания кишечника, энтеросолюбильное покрытие, эудрагит L, эудрагит S, рН-зависимое высвобождение

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8586/7541; Шелыгин ЮА, Ивашкин ВТ, Белоусова ЕА, Решетов ИВ, Маев ИВ, Ачкасов СИ и др. Язвенный колит (К51), взрослые. Колопроктология. 2023;22(1):10–44. https://doi.org/10.33878/2073-7556-2023-22-1-10-44.; Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM et al.; International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. https://doi.org/10.1053/j.gastro.2020.12.031.; Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl. A):5A–36A. https://doi.org/10.1155/2005/269076.; Truelove S, Witts L. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041–1048. https://doi.org/10.1136/bmj.2.4947.1041.; Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–1629. https://doi.org/10.1056/NEJM198712243172603.; Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2–17. https://doi.org/10.1093/ecco-jcc/jjab178.; Reinisch W, Reinink AR, Higgins PD. Factors associated with poor outcomes in adults with newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol. 2015;13(4):635–642. https://doi.org/10.1016/j.cgh.2014.03.037.; Абдулганиева ДИ, Бакулев АЛ, Белоусова ЕА, Веселов АВ, Коротаева ТВ, Лила АМ и др. Раннее назначение генно-инженерных биологических препаратов при иммуновоспалительных заболеваниях: возможности и перспективы. Позиция экспертов. Альманах клинической медицины. 2020;48(6):422–436. https://doi.org/10.18786/2072-0505-2020-48-050.; Dias CC, Rodrigues PP, da Costa-Pereira A, Magro F. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis. 2015;9(2):156–163. https://doi.org/10.1093/ecco-jcc/jju016.; Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S; AGA Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020;158(5):1450–1461. https://doi.org/10.1053/j.gastro.2020.01.006.; Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Management of Mildto-Moderate Ulcerative Colitis. Gastroenterology. 2019;156(3):748–764. https://doi.org/10.1053/j.gastro.2018.12.009.; Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK et al; IBD guidelines eDelphi consensus group, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl. 3):s1-s106. https://doi.org/10.1136/gutjnl-2019-318484.; Ситкин СИ. Возможности повышения эффективности терапии и комплайенса у пациентов с воспалительными заболеваниями кишечника с помощью инновационных препаратов перорального месалазина. Гастроэнтерология Санкт-Петербурга. 2011;(1):2–5. Режим доступа: http://gastroforum.ru/wp-content/uploads/2013/06/GSP_1_2011_2-5.pdf.; Yamamoto Y, Masuda S, Nakase H, Matsuura M, Maruyama S, Hisamatsu T et al. Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis. Biol Pharm Bull. 2019;42(1):81–86. https://doi.org/10.1248/bpb.b18-00561.; D’Incà R, Paccagnella M, Cardin R, Pathak S, Baldo V, Giron MC, Sturniolo GC. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis. World J Gastroenterol. 2013;19(34):5665–5670. https://doi.org/10.3748/wjg.v19.i34.5665.; Olaisen M, Spigset O, Flatberg A, Granlund AVB, Brede WR, Albrektsen G et al. Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis. Aliment Pharmacol Ther. 2019;49(10):1301–1313. https://doi.org/10.1111/apt.15227.; Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020;8(8):CD000543. https://doi.org/10.1002/14651858.CD000543.pub5.; D’Haens GR, Sandborn WJ, Zou G, Stitt LW, Rutgeerts PJ, Gilgen D et al. Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis. Aliment Pharmacol Ther. 2017;46(3):292–302. https://doi.org/10.1111/apt.14164.; Awadhi SA, Alboraie M, Albaba EA, Almutairdi A, Alsaad M, Azzam N et al. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus. J Clin Med. 2023;12(21):6929. https://doi.org/10.3390/jcm12216929.; Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020;8(8):CD000544. https://doi.org/10.1002/14651858.CD000544.pub5.; Белоусова ЕА, Халиф ИЛ, Абдулганиева ДИ, Алексеенко СА, Барановский АЮ, Валуйских ЕЮ и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018;46(5):445–463. https://doi.org/10.18786/2072-0505-2018-46-5-445-463.; Белоусова ЕА, Шелыгин ЮА, Ачкасов СИ, Хатьков ИЕ, Бакулин ИГ, Скалинская МИ и др. Клинико-демографические характеристики и лечебные подходы у пациентов с воспалительными заболеваниями кишечника (болезнь Крона, язвенный колит) в РФ. Первые результаты анализа национального Регистра. Колопроктология. 2023;22(1):65–82. https://doi.org/10.33878/2073-7556-2023-22-1-65-82.; Varma S, Hu J, Mehta A, Song Y, Park A, Zhi M, Hutfless S. Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China. JGH Open. 2019;3(3):234–241. https://doi.org/10.1002/jgh3.12146.; Marti-Aguado D, Ballester MP, Tosca J, Bosca-Watts MM, Navarro P, Anton R et al. Long-term follow-up of patients treated with aminosalicylates for ulcerative colitis: Predictive factors of response: An observational casecontrol study. United European Gastroenterol J. 2019;7(8):1042–1050. https://doi.org/10.1177/2050640619854277.; Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm. 2008;14(1 Suppl.): s2-12;quizs13-5. https://doi.org/10.18553/jmcp.2008.14.s1-a.1a.; Loftus EV Jr. A practical perspective on ulcerative colitis: patients’ needs from aminosalicylate therapies. Inflamm Bowel Dis. 2006;12(12):1107–1113. https://doi.org/10.1097/01.mib.0000235831.01682.8d.; Franco FCZ, Oliveira MCC, Gaburri PD, Franco DCZ, Chebli JMF. High prevalence of non-adherence to ulcerative colitis therapy in remission: knowing the problem to prevent loss. Arq Gastroenterol. 2022;59(1):40–46. https://doi.org/10.1590/S0004-2803.202200001-08.; Gillespie D, Hood K, Farewell D, Stenson R, Probert C, Hawthorne AB. Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):82–91. https://doi.org/10.1097/01.MIB.0000437500.60546.2a.; Dignass A, Schnabel R, Romatowski J, Pavlenko V, Dorofeyev A, Derova J et al.; International SAT-25 Study Group. Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a doubleblind, multicentre, randomised trial. United European Gastroenterol J. 2018;6(1):138–147. https://doi.org/10.1177/2050640617703842.; Sun J, Yuan Y. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Remission Phase: A Chinese, Multicenter, SingleBlind, Randomized Controlled Study. Adv Ther. 2016;33(3):410–422. https://doi.org/10.1007/s12325-016-0304-y.; Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0.; Jeuring SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE et al. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity? Inflamm Bowel Dis. 2016;22(6):1425–1434. https://doi.org/10.1097/MIB.0000000000000738.; Nguyen GC, Sheng L, Benchimol EI. Health Care utilization in elderly onset inflammatory bowel disease: a population-based study. Inflamm Bowel Dis. 2015;21(4):777–782. https://doi.org/10.1097/MIB.0000000000000306.; Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ et al.; Asia – Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158–165.e2. https://doi.org/10.1053/j.gastro.2013.04.007.; Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N et al. European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis. 2017;11(3):263–273. https://doi.org/10.1093/ecco-jcc/jjw188.; Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J et al; CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374(9701):1617–1625. https://doi.org/10.1016/S0140-6736(09)61302-7.; Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(2):309–315. https://doi.org/10.1002/ibd.23026.; Белоусова ЕА, Никитина НВ, Цодикова ОМ. Лечение язвенного колита легкого и среднетяжелого течения. Фарматека. 2013;(2):42–46. Режим доступа: https://pharmateca.ru/en/archive/article/8718.; Мустафин РИ. Интраполимерные сочетания химически комплементарных типов сополимеров Eudragit как новое направление в создании пероральных систем доставки и лекарственных форм с модифицированным высвобождением. Химико-­фармацевтический журнал. 2011;45(5):38–39. Режим доступа: http://chem.folium.ru/index.php/chem/article/view/61/61#.; Минушкин ОН, Топчий ТБ, Евсиков АЕ, Пюрвеева КВ, Бурдина ЕГ, Скибина ЮС, Кручинина МЮ. Консервативная терапия язвенного колита легкого и среднетяжелого течения. Лечение и профилактика. 2022;12(3):101–105. Режим доступа: https://www.elibrary.ru/item.asp?edn=nvkgzv.; Шапина МВ. Месалазин в индукции клинико-эндоскопической ремиссии легких и среднетяжелых форм язвенного колита. Медицинский совет. 2022;16(15):90–97. https://elibrary.ru/nvkgzv.; Князев ОВ, Каграманова АВ, Лищинская АА, Парфенов АИ. Эффективность терапии месалазинами язвенного колита средней степени тяжести в реальной клинической практике. Медицинский совет. 2019;(14):80–86. https://doi.org/10.21518/2079-701X-2019-14-80-86.

الاتاحة: https://www.med-sovet.pro/jour/article/view/8586
https://doi.org/10.21518/ms2024-446

المؤلفون: Lombardo, Rosamaria, Ruponen, Marika, Rautio, Jarkko, Ghelardini, Carla, Mannelli, Lorenzo Di Cesare, Calosi, Laura, Bani, Daniele, Lampinen, Riikka, Kanninen, Katja M., Koivisto, Anne M., Penttilä, Elina, Lopponen, Heikki, Pignatello, Rosario

المساهمون: Department of Neurosciences, HUS Neurocenter, HUS Internal Medicine and Rehabilitation, Geriatrian yksikkö, Neurologian yksikkö

مصطلحات موضوعية: Eudragit RL100, Eudragit RS100, Cryoprotectants, Mucoadhesion, Nanomedicine, Stability, 317 Pharmacy

وصف الملف: application/pdf

Relation: Lombardo , R , Ruponen , M , Rautio , J , Ghelardini , C , Mannelli , L D C , Calosi , L , Bani , D , Lampinen , R , Kanninen , K M , Koivisto , A M , Penttilä , E , Lopponen , H & Pignatello , R 2023 , ' Development of Lyophilised Eudragit((R)) Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration ' , Pharmaceutics , vol. 15 , no. 5 , 1554 . https://doi.org/10.3390/pharmaceutics15051554; ff39bb5d-3604-44a8-968f-bd075de5bae2; http://hdl.handle.net/10138/572922; 000997249600001

الاتاحة: http://hdl.handle.net/10138/572922

المؤلفون: Yasir Karkar, Moemen Hosny Deeb Hashem, Ahmed M Faheem

المصدر: British Journal of Pharmacy, Vol 8, Iss 2 (2023)

مصطلحات موضوعية: 3d printing, topical patches, salicylic acid, eudragit., eudragit, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.bjpharm.org.uk/article/1413/galley/1042/view/; https://doaj.org/toc/2058-8356

URL الوصول: https://doaj.org/article/60b1f26172394655947437e91b5a3baf

المؤلفون: Jie Gao, Yanan Sang, Xiaobing Han, Yuan Zhao, Tian Liang, Tao Chen

المصدر: Journal of Saudi Chemical Society, Vol 28, Iss 3, Pp 101864- (2024)

مصطلحات موضوعية: Drug release, 5-fluorouracil, Silica, Cellulose, Chitosan, Eudragit L100, Chemistry, QD1-999

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1319610324000590; https://doaj.org/toc/1319-6103

URL الوصول: https://doaj.org/article/a2332f8b459740bd8e5fb69822a3ed02